News

The Role of Molecular Analysis in Cutaneous Lymphomas

Knowing whether the lymphoma is primarily cutaneous or systemic and the subclassification of the tumor will allow the clinician to proceed with a more appropriate treatment plan.


 

Janyana M.D. Deonizio, MD, and Joan Guitart, MD

The purpose of this review is to summarize the most important molecular techniques for the diagnosis of cutaneous lymphomas. When making a diagnosis, we are looking for the solid clinicopathological correlation. Molecular analysis includes immunophenotyping and clonality analysis, and is important for 2 principal reasons: (1) to confirm the diagnosis in cases where the clinical and/or pathological presentations are nondiagnostic, and (2) to further characterize the nature of the lymphoma. More specifically, we are trying to discern whether the lymphoma is primarily cutaneous or systemic with secondary skin involvement, and we are also attempting to subclassify the tumor. Recently, many techniques have provided a more accurate diagnosis of cutaneous lymphomas and some prognostic implications, including polymerase chain reaction, fluorescence in situ hybridization, and flow cytometry. Fluorescence in situ hybridization is not routinely used in the diagnosis of cutaneous lymphoma, but many studies have shown potential future applications in various areas. Other techniques, such as comparative genomic hybridization, are still confined to the research arena, but have added some insight into the molecular pathogenesis of cutaneous T-cell lymphoma.

*For a PDF of the full article, click on the link to the left of this introduction.

Recommended Reading

Tanning Bed Risks Not Communicated to 73% of Germans
MDedge Dermatology
Imaging Unwarranted in Primary Cutaneous Melanoma
MDedge Dermatology
Merkel Cell Carcinoma Prognosis Linked to Vitamin D
MDedge Dermatology
Melanoma Treatment With Vemurafenib Can Trigger Leukemia
MDedge Dermatology
Innovative Methods of UV Protection
MDedge Dermatology
There's No Place for 'Dabbling' in Mohs Surgery
MDedge Dermatology
Molecular Platforms Utilized to Detect BRAF V600E Mutation in Melanoma
MDedge Dermatology
Molecular Diagnosis of Infection-Related Cancers in Dermatopathology
MDedge Dermatology
Molecular Diagnostics for Ambiguous Melanocytic Tumors
MDedge Dermatology
Broad-Spectrum Moisturizer Effectively Prevents Molecular Reactions to UVA Radiation
MDedge Dermatology